Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Matthew R. Leblanc"'
Autor:
Matthew R LeBlanc, Thomas W LeBlanc, Qing Yang, Jennifer McLaughlin, Kerry Irish, Sophia K Smith
Publikováno v:
JMIR Cancer, Vol 9, p e44533 (2023)
BackgroundPatients with blood cancer experience serious physical and emotional symptoms throughout their cancer journey. ObjectiveBuilding on previous work, we aimed to develop an app designed to help patients with multiple myeloma and chronic lymph
Externí odkaz:
https://doaj.org/article/41d939179e774fd2b45200454a87db63
Autor:
Katherine E. Reeder‐Hayes, Bradford E. Jackson, Christopher D. Baggett, Tzy‐Mey Kuo, Jacquelyne J. Gaddy, Matthew R. LeBlanc, Emily F. Bell, Laura Green, Stephanie B. Wheeler
Publikováno v:
Cancer. 129:925-933
Publikováno v:
Value in Health. 26:953-955
Autor:
Mark A. Fiala, Matthew R. Leblanc, Kathryn W. Coccia, Shraddha Bandaru, Alice E. Silberstein, Theresa Coles, Ravi Vij
Purpose Financial toxicity is a contributor to the psychosocial burden of cancer care. There is no consensus measure of financial toxicity, however, recent studies have adopted the COmprehensive Score for financial Toxicity (COST). Despite its growin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1a474d0ad92b9747a10f5927ecb07c2
https://doi.org/10.21203/rs.3.rs-2777936/v1
https://doi.org/10.21203/rs.3.rs-2777936/v1
Autor:
Thomas W. LeBlanc, Sheryl Zimmerman, Sophia K. Smith, Matthew R. LeBlanc, Ashley Leak Bryant, Kathryn Elizabeth Hudson
Publikováno v:
Leuk Lymphoma
This study describes the prevalence and persistence of fatigue among a cohort of long-term non-Hodgkin lymphoma (NHL) survivors. Mailed surveys assessed quality-of-life including fatigue (SF-36) at baseline and five years. Logistic regression was use
Autor:
Wei Pan, Sophia K. Smith, Matthew R. LeBlanc, Sarthya Amarasekara, Kelly E. Westbrook, Kristin MacDermott
Publikováno v:
Journal of Palliative Medicine. 23:353-358
Background: Anticipating and making health care decisions about appropriate or preferred treatment around end-of-life care are intellectually challenging and emotionally distressing for metastatic ...
Autor:
Matthew R. LeBlanc, Ashley Leak Bryant, Thomas W. LeBlanc, Qing Yang, Emily Sellars, Cristiana Costa Chase, Sophia K. Smith
Publikováno v:
Support Care Cancer
BACKGROUND: The purpose of this manuscript is to describe health-related quality of life (HRQoL) outcomes in a United States (US) based sample of multiple myeloma (MM) patients and identify characteristics associated with poor HRQoL. PATIENTS AND MET
Autor:
Christopher E Jensen, Sanah N Vohra, Kirsten A Nyrop, Allison M Deal, Matthew R LeBlanc, Shakira J Grant, Hyman B Muss, Eben I Lichtman, Samuel M Rubinstein, William A Wood, Nicholas J Mangieri, Lee Jamison, Sascha A Tuchman
Publikováno v:
The oncologist. 27(8)
BackgroundThe plasma cell disorders (PCDs), multiple myeloma (MM), and light-chain amyloidosis (AL) are disproportionately diseases of older adults, whose care may be complicated by frailty associated with advancing age. We sought to evaluate the pre
Publikováno v:
Qual Life Res
PURPOSE: Patients with relapsed and/or refractory multiple myeloma (RRMM) are living longer due in part to changing treatment patterns. It is important to understand how changing treatment patterns affect patients’ lives beyond extending survival.
Autor:
Kathryn I. Pollak, Ashley Leak Bryant, Donald E. Bailey, Sophia K. Smith, Thomas W. LeBlanc, Matthew R. LeBlanc
Publikováno v:
Oncol Nurs Forum
PURPOSE: Survival improvements in multiple myeloma (MM) over the past fifteen years have been fueled by the introduction of new therapies and changes in treatment patterns. The purpose of this study was to explore the ways MM impacts a person’s lif